You can buy or sell NVUS and other stocks, options, ETFs, and crypto commission-free!
Novus Therapeutics, Inc. Common Stock, also called Novus Therapeutics, is a pharmaceutical company, which engages in the acquisition, development, and commercialization of ear, nose, and throat products. Read More The firm's lead product, OP-02, is a surfactant-based, combination drug product being developed as a potential treatment option for patients at risk for or with otitis media, which is often caused by Eustachian tube dysfunction. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.
52 Week High
52 Week Low
Expected Mar 28, Pre-Market